Rigel Pharmaceuticals (RIGL) EBIT Margin (2010 - 2026)
Rigel Pharmaceuticals' EBIT Margin was 29.95% in Q2 2026, down 30.14 percentage points from 60.09% a year earlier but up 9.75 percentage points from the prior quarter.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) EBIT Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Rigel Pharmaceuticals' EBIT Margin was 31.45% through Jun 30, 2026, down 7.59 percentage points year-over-year; for FY2025, it came in at 42.63%, up 29.14 percentage points from FY2024.
- EBIT Margin has now increased for three consecutive years, with a five-year change of +69.31 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was 13.49% in FY2024 (+31.03 pp), -17.53% in FY2023 (+28.67 pp), -46.20% in FY2022 (-37.83 pp) and -8.37% in FY2021 (+18.30 pp).
- Quarterly EBIT Margin has moved between -156.92% (Q1 2022) and 60.09% (Q2 2025) over five years.
- Compared with a year earlier, EBIT Margin was higher in six of the last eight quarters, with an average year-over-year change of +19.63 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q4 2022 (a gain of 109.00 percentage points); the worst was Q1 2022 (a drop of 208.46 percentage points).
- Per Business Quant data, RIGL's EBIT Margin in the three quarters before Q2 2026 was 20.21% (Q1 2026), 33.19% (Q4 2025) and 40.91% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Rigel Pharmaceuticals | 922.04 Mn | 387.93 Mn | 70.18 Mn | 29.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.95% |
| Mar 31, 2026 | 20.21% |
| Dec 31, 2025 | 33.19% |
| Sep 30, 2025 | 40.91% |
| Jun 30, 2025 | 60.09% |
| Mar 31, 2025 | 23.95% |
| Dec 31, 2024 | 28.92% |
| Sep 30, 2024 | 25.41% |
| Jun 30, 2024 | 1.21% |
| Mar 31, 2024 | -23.59% |
| Dec 31, 2023 | 5.49% |
| Sep 30, 2023 | -15.87% |
| Jun 30, 2023 | -19.59% |
| Mar 31, 2023 | -48.81% |
| Dec 31, 2022 | 4.05% |
| Sep 30, 2022 | -82.12% |
| Jun 30, 2022 | -43.48% |
| Mar 31, 2022 | -156.92% |
| Dec 31, 2021 | -104.94% |
| Sep 30, 2021 | -91.84% |
API Access
Rigel Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=RIGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "RIGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=RIGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();